Detalhe da pesquisa
1.
[Changes resulting from the implementation of the new EU Clinical Trial Regulation 536/2014 from the perspective of patients]. / Veränderungen durch die neue EU-Verordnung 536/2014 zu klinischen Prüfungen aus Patientensicht.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 66(1): 68-74, 2023 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-36515718
2.
Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials.
Health Expect
; 23(1): 41-51, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722131
3.
Patient Confidence and Information Preferences During the Treatment Decision-making Process: Results From a Large Multiple Myeloma Patient Survey Across 12 Countries in Europe and Israel.
Clin Lymphoma Myeloma Leuk
; 23(5): e240-e251.e12, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967243
4.
What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Front Oncol
; 12: 1027353, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523996
5.
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
Front Med (Lausanne)
; 8: 686165, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295912
6.
Living with the burden of relapse in multiple myeloma from the patient and physician perspective.
Leuk Res
; 59: 75-84, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28582636